CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.
Analyst Elizabeth Anderson CFA of Evercore ISI maintained a Buy rating on CVSHealth (CVS – Research Report), retaining the price target of $75.00. Don't Miss our Black Friday Offers: Elizabeth ...